News + PR
Wheeler Bio Licenses ATUM’s Proprietary Leap-In Transposase® Technology in Support of its Disruptive CDMO Service Offering
December 14, 2022
News & Media
Learn what’s new at Wheeler Bio
Filter By
Articles
Reducing Time to IND, Increasing Quality, and Building Trust Through Shared Data
August 5, 2022
Articles
Applying an Advanced Pharma 4.0 Perspective to Design the Facility of the Future
August 5, 2022
Our Expert Team
Let’s Get Started
Wheeler is excited to collaborate on the path to accelerated clinical impact. Whether you’re an Innovator, a CRO, or a CDMO, we want to hear from you.